The Headline
the week's biggest story
life's first human trial: Yamanaka factors go into a human eye
Life Biosciences received FDA clearance to begin the first human trial of partial cellular reprogramming, targeting glaucoma and optic nerve damage. the trial delivers three Yamanaka factors (OSK, excluding c-Myc) via a modified virus into one eye of up to 18 patients, with an antibiotic-controlled switch limiting expression to reduce cancer risk. preclinical monkey studies showed no tumor formation, and participants will be followed for five years.
the trial uses the same OSK approach David Sinclair's Harvard lab used to restore vision in aging mice. Nobel laureate Shinya Yamanaka, who first described the four reprogramming factors in 2006, is a Life Biosciences scientific advisor.
(Source)
The Build
tools, models, and dev releases
- Anthropic launches Claude Managed Agents in public beta - the service handles sandboxing, state management, scoped permissions, and multi-hour sessions that survive network drops, priced at $0.08 per session-hour on top of standard API rates, removing the hardest infrastructure work from production agent builds (More)
- Vercel publishes a data-backed "Agentic Infrastructure" post - 30% of all Vercel deployments are now agent-initiated (up 1000% in six months, with Claude Code accounting for 75%), formally positioning AI SDK 6, AI Gateway, Fluid Compute, Workflows, Queues, and Sandbox as a unified agentic stack (More)
- Cursor Bugbot adds self-improving learned rules and MCP support - Bugbot now reads PR reactions and reviewer comments to create "learned rules" that shape future reviews; Teams and Enterprise users can also wire in MCP servers for external context, with resolution rate reported at 78% (More)
- Figma launches Weave, a node-based canvas for AI media workflows - the browser-based studio at weave.figma.com lets designers chain AI models for image generation, video conversion, and brand scaling, launching with 20+ community templates; deeper Figma platform integration is planned for later in 2026 (More)
- Astropad launches Workbench, a remote desktop built for monitoring AI agents - unlike legacy remote tools, Workbench uses Astropad's low-latency LIQUID protocol so developers can inspect logs, restart stalled tasks, and dictate prompts by voice to agents running on local hardware; $10/mo for macOS 15 and iOS 26 (More)
Founder Fuel
funding, acquisitions, and market moves
- Hermeus raises $350M Series C at $1B valuation to scale unmanned hypersonic aircraft - the round, split $200M equity and $150M debt, funds simultaneous multi-aircraft production and a move from Atlanta to El Segundo; backers include Khosla Ventures, Founders Fund, and In-Q-Tel (More)
- Bolt lays off 30% of staff as once-$11B fintech battles financial collapse - CEO Ryan Breslow framed the cuts as an AI pivot, but reports show the company has struggled to pay vendors including AWS, with its valuation cratering from $11B to roughly $300M on secondary markets (More)
- Collide Capital closes $95M Fund II oversubscribed, backed by Goldman Sachs and JPMorgan - the firm targets pre-seed through Series A for fintech, supply chain, and future-of-work startups, bringing total AUM to $170M+; LP line-up signals growing institutional capital flowing to the sector (More)
- Oracle begins cutting up to 30,000 jobs in AI-driven restructuring - analysts at TD Cowen estimate up to 18% of Oracle's 162,000-person workforce will be affected as the company reallocates costs toward cloud and AI infrastructure, with employees receiving same-day access revocations (More)
Longevity & Health
aging, biotech, and health research
- long COVID doubles cardiovascular risk in non-hospitalised adults, Stockholm cohort finds - analysis of 1.2 million health records found women with long COVID were twice as likely to develop arrhythmia, coronary artery disease, or heart failure compared to matched controls, even when the original infection was mild (More)
- aging liver cells hijack the bloodstream to accelerate cancer spread, Nature Aging study finds - senescent (zombie) liver cells release tiny vesicles packed with specific miRNAs that travel through blood to tumors and make them more invasive; senolytics like dasatinib and quercetin significantly blocked the process in aged mice (More)
- women's immune systems age more dramatically than men's, large single-cell study finds - profiling nearly 1,000 donors, the Nature Aging study found females show broader immune remodeling with age - including expansion of autoimmune-linked T-cell populations - while males accumulate a B-cell subtype associated with a precursor to chronic lymphocytic leukemia (More)
The World
regulation, policy, and geopolitics
- EU child-abuse detection law expires, leaving AI-generated CSAM in a legal vacuum - a temporary ePrivacy exemption that allowed Google, Meta, Snap, and Microsoft to voluntarily scan for child sexual abuse material lapsed April 3 without a replacement deal; a similar gap in 2021 caused a 58% drop in abuse reports, and the new void now covers AI-generated material too (More)
- Hungary votes tomorrow in the most contested election of Orbán's 16-year rule - independent pollster Medián shows Péter Magyar's Tisza party with a lead potentially sufficient for a parliamentary majority, which could shift Hungary's positions on Ukraine aid, EU sanctions enforcement, and internal cohesion debates (More)
- European airports warn of jet fuel shortages within three weeks if Hormuz stays restricted - ACI Europe told the European Commission on April 10 that 40-50% of Europe's jet fuel normally transits the Strait of Hormuz; the fragile US-Iran ceasefire has not restored normal shipping, threatening summer flight disruptions and surcharges (More)
Go Deeper
long reads, podcasts, and documentaries
- Sam Altman may control our future - can he be trusted? - The New Yorker | Ronan Farrow & Andrew Marantz. based on 100+ interviews and 70 pages of previously undisclosed memos compiled by Ilya Sutskever, the most reported examination yet of what OpenAI's board believed about Altman. (Read)
- Michael Nielsen - how science actually progresses - Dwarkesh Podcast | Dwarkesh Patel. a 2-hour dive into why scientific progress outpaces its verification loops - directly relevant for anyone thinking about closing the RL loop for AI-driven discovery, with surprising examples from Einstein, Darwin, and Aristarchus. (Listen)
- Fareed Zakaria on the moral cost of Trump's war - The Ezra Klein Show | Ezra Klein. Zakaria's breakdown of how Trump's Iran threats have accelerated the decline of American soft power - essential context for anyone raising capital or building across borders. (Listen)
- Vikings, Ragnar, Berserkers, Valhalla & the warriors of the Viking Age - Lex Fridman Podcast | Lex Fridman with Lars Brownworth. a nearly 2-hour history conversation with no AI angle - a useful mental-model reset about how small, networked groups of innovators repeatedly disrupted the established order of empires. (Listen)
The Colony
events and community
- tomorrow: April 12 - Agentic Coding Studio at Espresso House Mittelweg 130, Hamburg - agent builders gather for The Drop (max 15-min demos and hot takes) followed by open studio; for people orchestrating multi-agent workflows, not just AI-assisted coding (RSVP)
- next friday: April 17 - build fridays at SPACE, Am Sandtorkai 27, Hamburg - open-door co-working 4-11pm for founders actively shipping; come when you can, don't miss 7pm intros (RSVP)
a beaver in the wild lives roughly 10 years. a beaver in captivity lives up to 24 - not through Yamanaka factors or senolytic drugs, just the absence of things trying to eat it. Life Biosciences cleared its first human trial this week to reprogram cells with OSK gene therapy. the beaver considers this approach unnecessarily complicated but exciting.
stay curious,
Alex & Vlady
was this useful? just reply · share this with a friend · LinkedIn · Meetup